Paion Competitors and Similar CompaniesClear all
Array BioPharma's competitors and similar companies include ObsEva and Affimed N.V..
 Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. |  ObsEva ObsEva is a speciality biopharmaceutical company developing drugs for womens reproductive medicine. |  Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. | |
Founding Date | Founding Date 1998 | Founding Date 2012 | Founding Date 2000 |
Type | Type Subsidiary | Type Private | Type Public |
Tags | |||
Locations | Locations Boulder, US HQ Chicago, US Detroit, US Houston, US Miami, US New York, US Phoenix, US | Locations Plan-les-Ouates, CH HQ Boston, US Sacramento, US | Locations Heidelberg, DE HQ |
Employees | Employees 110 | Employees 811% decrease | Employees 76 |
Financial | |||
Revenue (est.) | Revenue (est.) $173.8m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) €8.3m (FY, 2023) |
Cost of goods | Cost of goods $59.4m (FY, 2018) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $114.4m (FY, 2018) | Gross profit N/A | Gross profit €13m (FY, 2023) |
Net income | Net income ($147.7m) (FY, 2018) | Net income N/A | Net income (€105.9m) (FY, 2023) |
For sources of this data, please see the company profile
View Company Profiles
ObsEva
HQ
Plan-les-Ouates, CH
Employees
8↓ 11% decrease
ObsEva is a speciality biopharmaceutical company developing drugs for womens reproductive medicine.
View companyAffimed N.V.
HQ
Heidelberg, DE
Employees
76
Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.
View company